Literature DB >> 3479500

Antibody-dependent cell-mediated cytotoxicity against cells infected with the human immunodeficiency virus.

R S Blumberg1, T Paradis, K L Hartshorn, M Vogt, D D Ho, M S Hirsch, J Leban, V L Sato, R T Schooley.   

Abstract

Human immunodeficiency virus (HIV) elicits the production of virus-specific antibodies in infected individuals. We investigated the ability of serum from HIV-infected individuals to mediate antibody-dependent cellular cytotoxicity in an in vitro 51Cr release assay system. Fresh peripheral blood mononuclear cells from healthy donors seronegative for HIV were used as cellular effectors against HIV-infected and uninfected H9 target cells in the presence of serum from HIV-infected or uninfected donors. Serum from HIV-infected, but not uninfected, donors significantly augmented cytolysis of virus-infected targets (P less than .005). There was no augmented killing of uninfected H9 cells with sera from either group. Studies using serum from mice that had been immunized with synthetic peptides from the HIV envelope region suggested that this response is directed, at least in part, at several determinants of the transmembrane portion of the HIV envelope glycoprotein.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3479500     DOI: 10.1093/infdis/156.6.878

Source DB:  PubMed          Journal:  J Infect Dis        ISSN: 0022-1899            Impact factor:   5.226


  17 in total

Review 1.  Cellular and humoral antigenic epitopes in HIV and SIV.

Authors:  D F Nixon; K Broliden; G Ogg; P A Broliden
Journal:  Immunology       Date:  1992-08       Impact factor: 7.397

2.  Interference with human immunodeficiency virus (HIV) replication by CD8+ T cells in peripheral blood leukocytes of asymptomatic HIV carriers in vitro.

Authors:  M Kannagi; T Masuda; T Hattori; T Kanoh; K Nasu; N Yamamoto; S Harada
Journal:  J Virol       Date:  1990-07       Impact factor: 5.103

3.  Deficient antibody-dependent cellular cytotoxicity against human immunodeficiency virus (HIV)-expressing target cells in perinatal HIV infection.

Authors:  U Ziegner; D Campbell; K Weinhold; I Frank; R Rutstein; S E Starr
Journal:  Clin Diagn Lab Immunol       Date:  1999-09

4.  The Role of the Envelope Glycoprotein in the Depletion of T Helper Cells in Human Immunodeficiency Virus Infection.

Authors:  Christian Jassoy; Martin Heinkelein; Sieghart Sopper
Journal:  Pathol Oncol Res       Date:  1997       Impact factor: 3.201

5.  Antibodies to CD4 in individuals infected with human immunodeficiency virus type 1.

Authors:  M Kowalski; B Ardman; L Basiripour; Y C Lu; D Blohm; W Haseltine; J Sodroski
Journal:  Proc Natl Acad Sci U S A       Date:  1989-05       Impact factor: 11.205

6.  Antibody-dependent cellular cytotoxicity and neutralizing activity in sera of HIV-1-infected mothers and their children.

Authors:  K Broliden; E Sievers; P A Tovo; V Moschese; G Scarlatti; P A Broliden; C Fundaro; P Rossi
Journal:  Clin Exp Immunol       Date:  1993-07       Impact factor: 4.330

7.  Preclinical studies of human immunodeficiency virus/AIDS vaccines: inverse correlation between avidity of anti-Env antibodies and peak postchallenge viremia.

Authors:  Jun Zhao; Lilin Lai; Rama Rao Amara; David C Montefiori; Francois Villinger; Lakshmi Chennareddi; Linda S Wyatt; Bernard Moss; Harriet L Robinson
Journal:  J Virol       Date:  2009-02-18       Impact factor: 5.103

8.  Antibody-dependent cellular cytotoxicity detects type- and strain-specific antigens among human immunodeficiency virus types 1 and 2 and simian immunodeficiency virus SIVmac isolates.

Authors:  K Ljunggren; G Biberfeld; M Jondal; E M Fenyö
Journal:  J Virol       Date:  1989-08       Impact factor: 5.103

9.  Qualitative analyses of cellular immune functions in equine infectious anemia show homology with AIDS.

Authors:  M Gerencer; I Valpotić; B Jukić; M Tomasković; I Basić
Journal:  Arch Virol       Date:  1989       Impact factor: 2.574

10.  Failure of ADCC to predict HIV-associated disease progression or outcome in a haemophiliac cohort.

Authors:  A Dalgleish; A Sinclair; M Steel; D Beatson; C Ludlam; J Habeshaw
Journal:  Clin Exp Immunol       Date:  1990-07       Impact factor: 4.330

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.